Cell-free Assays (IC50/Ki) for Capecitabine

Key TargetIC50 (Cell-free)DescriptionReference
No published data available.

Cell-based Assay (IC50) for Capecitabine

Cell TypeIC50 (Cell-based)DescriptionReference
MCF-7 cells 37.11 ± 4.8 µg/mL MTT (3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide) assay, dose–response curves with non-linear regression analysis in GraphPad Prism software. PMC12503056
SKBR3 cells 26.81 ± 4.5 µg/mL MTT (3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide) assay, dose–response curves with non-linear regression analysis in GraphPad Prism software. PMC12503056
SW-620 5 mM MTT assay, dose-response curve, GraphPad Prism version 9.0. Download PDF
HCT-116 4.78 ± 0.07 mM MTT assay Download PDF
HT-29 1.94 ± 0.77 mM MTT assay Download PDF
Check the Capecitabine product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.

Jump to